XML 69 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Compensation
12 Months Ended
Mar. 30, 2013
Equity Compensation [Abstract]  
Equity Compensation

11.      Equity Compensation

 

The Company is currently granting equity awards from the 2006 Stock Incentive Plan (the “Plan”), which was approved by stockholders in July 2006.  The Plan provides for granting of stock options, restricted stock awards, restricted stock units, performance awards, phantom stock awards, and bonus stock awards, or any combination of the foregoing.  To date, the Company has granted stock options, restricted stock awards, and restricted stock units under the Plan.  Stock options generally vest between zero and four years, and are exercisable for a period of ten years from the date of grant.  Generally, restricted stock awards are subject to vesting schedules up to four years.  Restricted stock units are generally subject to vesting from one to three years, depending upon the terms of the grant.

 

 

The following table summarizes the activity in total shares available for grant (in thousands):

 

 

 

 

 

 

 

 

 

Shares

 

 

Available for

 

 

Grant

Balance, March 27, 2010

 

9,930 

Plans terminated

 

(300)

Granted

 

(1,927)

Forfeited

 

472 

Balance, March 26, 2011

 

8,175 

Plans terminated

 

(34)

Granted

 

(2,049)

Forfeited

 

165 

Balance, March 31, 2012

 

6,257 

Plans terminated

 

 -

Granted

 

(1,600)

Forfeited

 

468 

Balance, March 30, 2013

 

5,125 

 

Stock Compensation Expense

 

The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for options granted under the Company’s equity incentive plans (in thousands, except per share amounts):  

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

 

March 30, 2013

 

 

March 31, 2012

 

 

March 26, 2011

Cost of sales

$

751 

 

$

398 

 

$

243 

Research and development

 

10,549 

 

 

5,590 

 

 

2,641 

Sales, general and administrative

 

10,195 

 

 

6,190 

 

 

5,257 

Effect on pre-tax income

 

21,495 

 

 

12,178 

 

 

8,141 

Income Tax Benefit

 

(106)

 

 

 -

 

 

 -

Total share-based compensation expense (net of taxes)

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on basic earnings per share

$

0.33 

 

$

0.19 

 

$

0.12 

Share-based compensation effects on diluted earnings per share

 

0.32 

 

 

0.18 

 

 

0.11 

Share-based compensation effects on operating activities cash flow

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on financing activities cash flow

 

106 

 

 

 -

 

 

 -

            The total share based compensation expense included in the table above and which is attributable to restricted stock awards and restricted stock units was $16.3 million, $6.3 million, and $1.1 million for fiscal years 2013, 2012, and 2011, respectively.

 

            As of March 30, 2013, there was $39.7 million of compensation costs related to non-vested stock options, restricted stock awards, and restricted stock units granted under the Company’s equity incentive plans not yet recognized in the Company’s financial statements.  The unrecognized compensation cost is expected to be recognized over a weighted average period of 0.96 years for stock options, 1.27 years for restricted stock awards, and 1.57 years for restricted stock units.

 

Stock Option Awards

 

We estimated the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

March 30, 2013

(a)

 

March 31, 2012

 

 

March 26, 2011

 

Expected stock price volatility

 

63.42

%

 

59.25 - 66.11

%

 

52.03 - 67.11

%

Risk-free interest rate

 

0.31

%

 

0.27 - 1.43

%

 

1.19 - 2.06

%

Expected term (in years)

 

2.46

 

 

2.32 - 3.82

 

 

3.83 - 4.34

 

   

(a)

 Actual assumptions at time of share issuance used.

 

The Black-Scholes valuation calculation requires us to estimate key assumptions such as stock price volatility, expected term, risk-free interest rate and dividend yield.  The expected stock price volatility is based upon implied volatility from traded options on our stock in the marketplace.  The expected term of options granted is derived from an analysis of historical exercises and remaining contractual life of stock options, and represents the period of time that options granted are expected to be outstanding.  The risk-free interest rate reflects the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term assumption.  Finally, we have never paid cash dividends, do not currently intend to pay cash dividends, and thus have assumed a zero percent dividend yield.

 

Using the Black-Scholes option valuation model, the weighted average estimated fair values of employee stock options granted in fiscal years 2013, 2012, and 2011, were $20.43, $7.58, and $9.61, respectively. 

 

During fiscal year 2013, 2012, and 2011, we received a net $12.0 million, $4.1 million, and $31.0 million, respectively, from the exercise of 1.7 million, 0.6 million and 4.7 million, respectively, stock options granted under the Company’s stock Plan.

 

The total intrinsic value of stock options exercised during fiscal year 2013, 2012, and 2011, was $48.6 million, $7.6 million, and $50.4 million, respectively.  Intrinsic value represents the difference between the market value of the Company’s common stock at the time of exercise and the strike price of the stock option.

 

As of March 30, 2013, approximately 9.4 million shares of common stock were reserved for issuance under the stock option Plan.  

 

 

Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding Options

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number

 

 

Exercise Price

Balance, March 27, 2010

 

10,379 

 

$

6.74 

Options granted

 

977 

 

 

16.75 

Options exercised

 

(4,718)

 

 

6.57 

Options forfeited

 

(153)

 

 

5.90 

Options expired

 

(304)

 

 

23.68 

Balance, March 26, 2011

 

6,181 

 

$

7.63 

Options granted

 

450 

 

 

15.63 

Options exercised

 

(593)

 

 

6.88 

Options forfeited

 

(67)

 

 

7.70 

Options expired

 

(67)

 

 

15.68 

Balance, March 31, 2012

 

5,904 

 

$

8.23 

Options granted

 

264 

 

 

37.22 

Options exercised

 

(1,746)

 

 

6.88 

Options forfeited

 

(144)

 

 

12.52 

Options expired

 

 -

 

 

20.25 

Balance, March 30, 2013

 

4,278 

 

$

10.42 

 

Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 30, 2013 is as follows (in thousands, except years and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Number of

 

 

Average

 

Remaining Contractual

 

 

Aggregate

 

 

Options

 

 

Exercise price

 

Term (years)

 

 

Intrinsic Value

Vested and expected to vest

 

4,196 

 

$

10.15 

 

6.07 

 

$

56,376 

Exercisable

 

3,217 

 

$

7.76 

 

5.51 

 

$

48,228 

 

In accordance with U.S. GAAP, stock options outstanding that are expected to vest are presented net of estimated future option forfeitures, which are estimated as compensation costs are recognized.  Options with a fair value of $4.8 million, $6.3 million, and $6.0 million, became vested during fiscal years 2013, 2012, and 2011, respectively.

 

The following table summarizes information regarding outstanding and exercisable options as of March 30, 2013 (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Weighted

 

 

 

Weighted

 

 

 

 

Contractual Life

 

Average Exercise

 

Number

 

Average

Range of Exercise Prices

 

Number

 

(years)

 

Price

 

Exercisable

 

Exercise Price

$2.59 - $5.25

 

764 

 

4.78 

 

$

5.05 

 

754 

 

$

5.05 

$5.49 - $5.53

 

58 

 

6.39 

 

 

5.50 

 

44 

 

 

5.50 

$5.55 - $5.55

 

1,217 

 

6.48 

 

 

5.55 

 

961 

 

 

5.55 

$5.66 - $7.87

 

891 

 

4.10 

 

 

7.05 

 

873 

 

 

7.05 

$8.06 - $16.25

 

874 

 

7.72 

 

 

15.18 

 

434 

 

 

14.90 

$16.28 - $38.99

 

474 

 

8.11 

 

 

29.79 

 

151 

 

 

19.60 

 

 

4,278 

 

6.11 

 

$

10.42 

 

3,217 

 

$

7.76 

               As of March 30, 2013 and March 31, 2012, the number of options exercisable was 3.2 million and 3.8 million, respectively.

 

Restricted Stock Awards

 

The Company periodically grants restricted stock awards (“RSA’s”) to select employees.  The grant date for these awards is equal to the measurement date and the awards are valued as of the measurement date and amortized over the requisite vesting period, which is no more than four years.  Each full value award, including RSA’s, reduces the total shares available for grant under the Plan at a rate of 1.5 shares per RSA granted.  As of March 30, 2013, approximately 0.1 million shares attributable to RSA awards were reserved for issuance under the Plan.  A summary of the activity for RSA’s in fiscal year 2013, 2012, and 2011 is presented below (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

Aggregate

 

Number of

 

 

Fair Value

Intrinsic 

 

Shares

 

 

(per share)

value (1)

March 27, 2010

49 

 

$

6.20 

 

Granted

 

 

17.28 

 

Vested

(7)

 

 

7.35 
134 

Forfeited

(2)

 

 

7.35 

 

March 26, 2011

45 

 

 

7.21 

 

Granted

49 

 

 

15.31 

 

Vested

(54)

 

 

14.57 
826 

Forfeited

    -

 

 

    -

 

March 31, 2012

40 

 

 

7.19 

 

Granted

27 

 

 

28.24 

 

Vested

(62)

 

 

15.45 
1,657 

Forfeited

 -

 

 

 -

 

March 30, 2013

 

$

17.28 

 

 

(1)

Represents the value of Cirrus stock on the date that the restricted stock vested.

            The weighted average remaining recognition period for RSA’s outstanding as of March 30, 2013 was 1.27 years.  RSA’s with a fair value of $951 thousand, $637 thousand, and $37 thousand became vested during fiscal years 2013, 2012, and 2011, respectively.

 

Restricted Stock Units

 

            Commencing in fiscal year 2011, the Company began granting restricted stock units (“RSU’s”) to select employees. These awards are valued as of the grant date and amortized over the requisite vesting period.  Generally, RSU’s vest 100 percent on the first to third anniversary of the grant date depending on the vesting specifications.  Each full value award, including RSU’s, reduces the total shares available for grant under the 2006 option plan at a rate of 1.5 shares per RSU granted.  As of March 30, 2013, approximately 3.2 million shares attributable to RSU awards were reserved for issuance under the Plan, which includes the additional shares associated with this full value award multiplier. A summary of the activity for RSU’s in fiscal year 2013, 2012, and 2011 is presented below (in thousands, except year and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

Weighted

Remaining

 

 

 

 

Average

Contractual Term

 

Shares

 

 

Fair Value

(years)

March 27, 2010

 -

 

$

 -

 

Granted

628 

 

 

16.41 

 

Vested

 -

 

 

 -

 

Forfeited

(8)

 

 

16.25 

 

March 26, 2011

620 

 

 

16.41 

2.54

Granted

1,017 

 

 

16.59 

 

Vested

 -

 

 

 -

 

Forfeited

(21)

 

 

16.04 

 

March 31, 2012

1,616 

 

 

16.52 

1.94

Granted

864 

 

 

37.26 

 

Vested

(193)

 

 

20.56 

 

Forfeited

(216)

 

 

21.46 

 

March 30, 2013

2,071 

 

$

23.66 

1.57

 

       Additional information with regards to outstanding restricted stock units that are vesting or expected to vest as of March 30, 2013, is as follows (in thousands, except year and per share amounts): 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Average

 

Remaining Contractual

 

 

Shares

 

 

Fair Value

 

Term (years)

Vested and expected to vest

 

1,888

 

$

23.66

 

1.53

 

            RSU’s outstanding that are expected to vest are presented net of estimated future forfeitures, which are estimated as compensation costs are recognized.  RSU’s with a fair value of $3.8 million became vested during fiscal year 2013.  No RSU’s became vested during fiscal year 2012 or 2011.  In fiscal year 2013, the Company required employees with vested RSU’s the option to cash settle or net settle, removing the option to sell all.  As a result, the Company repurchases a portion of the shares at fair value, and uses the cash on behalf of the employee to satisfy the tax withholding requirements.  In fiscal year 2013, the vesting of RSU’s reduced the authorized and unissued share balance by approximately 0.2 million, while the net released, outstanding share balance increased by approximately 0.1 million shares and resulted in the $1.7 million payment and subsequent retirement of these shares out of the Plan.